Senior Director, Market Access - Lilly Regenerative Medicine (LRM)
accountability for cross-asset consistency — e.g., ensuring wet AMD and an ultra-rare gene therapy don't set pricing or contracting
accountability for cross-asset consistency — e.g., ensuring wet AMD and an ultra-rare gene therapy don't set pricing or contracting
and ANGPTL3 to lower LDL-C, the root cause of cardiovascular disease. The Senior Director, Trial Management provides strategic
, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1. Additional Skills/Preferences: Prior experience with RNAseq
, including but not limited to F-1 CPT, F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1 Additional Skills
for or sponsor work authorization or visas for this role, including but not limited to F-1 CPT, F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN
Tell us what is wrong with this job. After review it may be removed.